APO RESEARCH · REPORT
Acne Medicine
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
Product & engineering
Understand the product.
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
Selected research
Industry Growth & Trends
Global Acne Medicine Industry Growth and Trends Forecast to 2032
Market perspective
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
According to APO Research, the global Acne Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Acne Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Acne Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acne Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acne Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Acne Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Acne Medicine Market by Company
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Acne Medicine Segment by Type
OTC
Prescription Medicine
Acne Medicine Segment by Application
Topical
Oral
Acne Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acne Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acne Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acne Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Acne Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Prescription Medicine
Applications
- Topical
- Oral
Companies covered
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Acne Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Acne Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Acne Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Acne Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Acne Medicine Market Size (2021-2032)
- 1.5.1 North America Acne Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Acne Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Acne Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Acne Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Acne Medicine Market Size Growth Rate (2021-2032)
2 Acne Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 OTC
- 2.1.2 Prescription Medicine
- 2.2 Global Acne Medicine Market Size by Type
- 2.2.1 Global Acne Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Acne Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Acne Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Acne Medicine Market Size by Regions
- 2.3.1 North America Acne Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Acne Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Acne Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Acne Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Acne Medicine Market Size Breakdown by Type (2021-2026)
3 Acne Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Topical
- 3.1.2 Oral
- 3.2 Global Acne Medicine Market Size by Application
- 3.2.1 Global Acne Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Acne Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Acne Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Acne Medicine Market Size by Regions
- 3.3.1 North America Acne Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Acne Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Acne Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Acne Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Acne Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Acne Medicine Industry Trends
- 4.2 Acne Medicine Industry Drivers
- 4.3 Acne Medicine Industry Opportunities and Challenges
- 4.4 Acne Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Acne Medicine Revenue (2021-2026)
- 5.2 Global Acne Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Acne Medicine Key Company Headquarters & Area Served
- 5.4 Global Acne Medicine Company, Product Type & Application
- 5.5 Global Acne Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Acne Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Acne Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Acne Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Galderma
- 6.1.1 Galderma Company Information
- 6.1.2 Galderma Business Overview
- 6.1.3 Galderma Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Galderma Acne Medicine Product Portfolio
- 6.1.5 Galderma Recent Developments
- 6.2 Bausch Health
- 6.2.1 Bausch Health Company Information
- 6.2.2 Bausch Health Business Overview
- 6.2.3 Bausch Health Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bausch Health Acne Medicine Product Portfolio
- 6.2.5 Bausch Health Recent Developments
- 6.3 Teva
- 6.3.1 Teva Company Information
- 6.3.2 Teva Business Overview
- 6.3.3 Teva Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Teva Acne Medicine Product Portfolio
- 6.3.5 Teva Recent Developments
- 6.4 GlaxoSmithKline
- 6.4.1 GlaxoSmithKline Company Information
- 6.4.2 GlaxoSmithKline Business Overview
- 6.4.3 GlaxoSmithKline Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GlaxoSmithKline Acne Medicine Product Portfolio
- 6.4.5 GlaxoSmithKline Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mylan Acne Medicine Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Almirall
- 6.6.1 Almirall Company Information
- 6.6.2 Almirall Business Overview
- 6.6.3 Almirall Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Almirall Acne Medicine Product Portfolio
- 6.6.5 Almirall Recent Developments
- 6.7 Sun Pharma
- 6.7.1 Sun Pharma Company Information
- 6.7.2 Sun Pharma Business Overview
- 6.7.3 Sun Pharma Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Sun Pharma Acne Medicine Product Portfolio
- 6.7.5 Sun Pharma Recent Developments
- 6.8 Mayne Pharma
- 6.8.1 Mayne Pharma Company Information
- 6.8.2 Mayne Pharma Business Overview
- 6.8.3 Mayne Pharma Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Mayne Pharma Acne Medicine Product Portfolio
- 6.8.5 Mayne Pharma Recent Developments
- 6.9 Lion
- 6.9.1 Lion Company Information
- 6.9.2 Lion Business Overview
- 6.9.3 Lion Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Lion Acne Medicine Product Portfolio
- 6.9.5 Lion Recent Developments
- 6.10 HUAPONT
- 6.10.1 HUAPONT Company Information
- 6.10.2 HUAPONT Business Overview
- 6.10.3 HUAPONT Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 HUAPONT Acne Medicine Product Portfolio
- 6.10.5 HUAPONT Recent Developments
- 6.11 Sine Pharma
- 6.11.1 Sine Pharma Company Information
- 6.11.2 Sine Pharma Business Overview
- 6.11.3 Sine Pharma Acne Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sine Pharma Acne Medicine Product Portfolio
- 6.11.5 Sine Pharma Recent Developments
7 North America
- 7.1 North America Acne Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Acne Medicine Market Size by Country (2021-2026)
- 7.3 North America Acne Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Acne Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Acne Medicine Market Size by Country (2021-2026)
- 8.3 Europe Acne Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Acne Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Acne Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Acne Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Acne Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Acne Medicine Market Size by Country (2021-2026)
- 10.3 South America Acne Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Acne Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Acne Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Acne Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst